Status:
UNKNOWN
MUSCLE - Nordic Walking in MUltiple SCLErosis
Lead Sponsor:
Leonardo A. Peyré-Tartaruga
Collaborating Sponsors:
Aline Nogueira Haas
Flávia Gomes Martinez
Conditions:
Multiple Sclerosis, Chronic Progressive
Multiple Sclerosis
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
The aim of the study is to analyze the effects of Nordic Walking and free walking in the clinical-functional, postural balance, motor control, muscular echographic quality, and gait analysis (pendulum...
Detailed Description
Objective: Analyze the effects of Nordic Walking and free walking in the clinical-functional parameters, postural balance, muscular echography quality, pendulum gait mechanism, in people with Multiple...
Eligibility Criteria
Inclusion
- volunteers aged over 20 years;
- of both sexes;
- with a clinical diagnosis of multiple sclerosis.
Exclusion
- severe heart diseases, uncontrolled hypertension, myocardial infarction within a period of less than one year, being a pacemaker;
- stroke or other associated neurological diseases; insanity;
- prostheses in the lower limbs;
- without ambulation conditions.
Key Trial Info
Start Date :
August 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05385731
Start Date
August 2 2022
End Date
December 30 2024
Last Update
May 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade Federal do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil, 90690-200